So are U buying at these levels ? I added at $3.68 .... sentiment is very negative but when you consider cash on hand , tax loss carry forwards ( if I have that right) and the EU market ... seems worth a spec buy . I have low expectations for the US market but believe Vascepa will be cost effective in the wealthier EU countries ... so will eventually make $ there But it’s likely to be slow going and we could easily test today’s low Kiwi